ADVENT at IDS 2024 | Navigating the Complexities of Atopic Dermatitis and Prurigo Nodularis: A Clinical Toolkit for Practitioners

Join experts Drs. Raja Sivamani and Jason Hawkes at an ADVENT educational symposium at IDS 2024 where they will discuss diagnosis and how clinical signs and itch in atopic dermatitis and prurigo nodularis are impacted by type 2 inflammation.

MD, MS

Jason Hawkes +1 more

Past event

29September2024

Location

Loews Arlington Hotel and Convention Center

888 Nolan Ryan Expressway 76011 Arlington, Texas

Symposium Details

September 29

ADVENT at IDS 2024 | Navigating the Complexities of Atopic Dermatitis and Prurigo Nodularis: A Clinical Toolkit for Practitioners

Learning objectives

Identify diagnostic considerations and challenges associated with atopic dermatitis and prurigo nodularis
Describe how clinical signs and itch in atopic dermatitis and prurigo nodularis are impacted by type 2 inflammation

Location

Loews Arlington Hotel and Convention Center

888 Nolan Ryan Expressway 76011 Arlington, Texas

Speakers

Dermatology

MD, MS

Jason Hawkes

Dr. Hawkes is a board-certified dermatologist and Investigator at the Oregon Medical Research Center in Portland, OR and is a current Councilor in the International Psoriasis Council and serves on the NPF Medical Board and Scientific Advisory Committee

Dermatology

MD, MS

Raja Sivamani

Dr. Raja Sivamani is a board-certified dermatologist and practices as an integrative dermatologist at Pacific Skin Institute and an Adjunct Associate Professor of Clinical Dermatology at the University of California, Davis, and Director of Clinical Research and the Clinical Trials Unit.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region